145 related articles for article (PubMed ID: 3132979)
1. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
[TBL] [Abstract][Full Text] [Related]
2. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A
Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930
[TBL] [Abstract][Full Text] [Related]
3. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
Kroon AA; Stalenhoef AF; Buikema H; Demacker PN; de Wilde PC; Leijten PA; van Gilst WH
Atherosclerosis; 1993 Nov; 103(2):221-30. PubMed ID: 8292097
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Tsujita Y; Horikoshi H
Atherosclerosis; 1999 Feb; 142(2):345-53. PubMed ID: 10030386
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T
Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
[TBL] [Abstract][Full Text] [Related]
7. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
8. The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.
Arbeeny CM; Bergquist KE
Biochim Biophys Acta; 1991 Apr; 1096(3):238-44. PubMed ID: 1902119
[TBL] [Abstract][Full Text] [Related]
9. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
[TBL] [Abstract][Full Text] [Related]
10. [Research and development of pravastatin].
Kishida Y; Naito A; Iwado S; Terahara A; Tsujita Y
Yakugaku Zasshi; 1991 Sep; 111(9):469-87. PubMed ID: 1762049
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
Martínez-González J; Alfón J; Berrozpe M; Badimon L
Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
[TBL] [Abstract][Full Text] [Related]
14. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
15. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
[TBL] [Abstract][Full Text] [Related]
16. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species.
Tsujita Y; Kuroda M; Shimada Y; Tanzawa K; Arai M; Kaneko I; Tanaka M; Masuda H; Tarumi C; Watanabe Y
Biochim Biophys Acta; 1986 Jun; 877(1):50-60. PubMed ID: 3636158
[TBL] [Abstract][Full Text] [Related]
17. [Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits].
Oogushi K
Fukuoka Igaku Zasshi; 1991 Feb; 82(2):36-47. PubMed ID: 2022360
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
[TBL] [Abstract][Full Text] [Related]
19. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
20. Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
Wajima T; Makita S; Oshima K
Pharmacology; 2004 Mar; 70(3):123-9. PubMed ID: 14752232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
